000 01034 a2200325 4500
005 20250512050939.0
264 0 _c19880627
008 198806s 0 0 eng d
022 _a0340-5354
024 7 _a10.1007/BF00314361
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPerrild, H
245 0 0 _aUndetectable thyrotropin levels using immunoradiometric assay in L-dopa-treated patients.
_h[electronic resource]
260 _bJournal of neurology
_cMar 1988
300 _a255 p.
_bdigital
500 _aPublication Type: Letter
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLevodopa
_xtherapeutic use
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aParkinson Disease
_xblood
650 0 4 _aRadioimmunoassay
_xmethods
650 0 4 _aThyrotropin
_xblood
700 1 _aMøller, A
700 1 _aPedersen, H
700 1 _aSiersbaek-Nielsen, K
773 0 _tJournal of neurology
_gvol. 235
_gno. 4
_gp. 255
856 4 0 _uhttps://doi.org/10.1007/BF00314361
_zAvailable from publisher's website
999 _c3378982
_d3378982